ADVENTRX Receives Positive SeekingAlpha Mention (ANX)

ADVENTRX ANX has received a positive SeekingAlpha mention in an article that can be found here. The article mentions the company's likely "run-up" prior to a September 1st FDA decision date. The author, who discloses a long position in ADVENTRX, says, "I think the stock could trade within the $4-5 range on a run-up basis going into the 9/1/11 FDA decision date, which would value the company at approximately $100M after subtracting for the cash balance."